These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 859862)

  • 1. Cyproheptadine blockade of a cardiogenic hypertensive chemoreflex.
    Hageman GR; Urthaler F; James TN
    Proc Soc Exp Biol Med; 1977 Apr; 154(4):578-81. PubMed ID: 859862
    [No Abstract]   [Full Text] [Related]  

  • 2. Blocking effects of cyproheptadine and methysergide upon two different cardiovascular responses to serotonin.
    Hageman GR; James TN; Urthaler F
    Proc Soc Exp Biol Med; 1980 Dec; 165(3):420-3. PubMed ID: 7465555
    [No Abstract]   [Full Text] [Related]  

  • 3. Neural pathways of a cardiogenic hypertensive chemoreflex.
    Hageman GR; Urthaler F; James TN
    Am J Physiol; 1978 Sep; 235(3):H345-9. PubMed ID: 696846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Centrally mediated antihypertensive and bradycardic effects of methysergide in spontaneously hypertensive rats.
    Antonaccio MJ; Coté D
    Eur J Pharmacol; 1976 Apr; 36(2):451-4. PubMed ID: 1278233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of 5-hydroxytryptamine and narcotic analgesics on dog intestine in vivo.
    de Oliveira LF; Sollero L
    Pharmacology; 1973; 10(5):291-7. PubMed ID: 4764535
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacologic analysis of chronotropic and inotropic responses to 5-hydroxytryptamine in the dog heart.
    Chiba S
    Jpn J Pharmacol; 1977 Oct; 27(5):727-34. PubMed ID: 22772
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies of changes in breathing and blood pressure accompanying a cardiogenic hypertensive chemoreflex compared in conscious and anesthetized dogs.
    Hageman GR; James TN; Urthaler F
    Am Heart J; 1983 Sep; 106(3):547-53. PubMed ID: 6881029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cardiogenic hypertensive chemoreflex.
    James TN
    Anesth Analg; 1989 Nov; 69(5):633-46. PubMed ID: 2679232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further studies of the pharmacology of the pyloric region. Analysis of the effects of intra-arterial histamine, serotonin, phenyldiguanide, morphine, and other drugs on the antrum and duodenal bulb.
    Daniel EE
    Can J Physiol Pharmacol; 1966 Nov; 44(6):981-1019. PubMed ID: 4381915
    [No Abstract]   [Full Text] [Related]  

  • 10. Parasympathetic and sympathetic efferent traffic during a cardiogenic hypertensive chemoreflex.
    Hageman GR; Urthaler F; James TN
    Cardiovasc Res; 1984 Sep; 18(9):583-90. PubMed ID: 6467275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the mechanism of the coronary dilator effect of serotonin in the dog.
    Mena MA; Vidrio H
    Eur J Pharmacol; 1976 Mar; 36(1):1-5. PubMed ID: 1261588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct and vagally mediated chronotropic effects of morphine studied by selective perfusion of the sinus node of awake dogs.
    Urthaler F; Isobe JH; James TN
    Chest; 1975 Aug; 68(2):222-8. PubMed ID: 238796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonidine attenuation of a cardiogenic hypertensive chemoreflex.
    Hageman GR; Urthaler F; James TN; Swatzell RH
    Hypertension; 1981; 3(2):240-4. PubMed ID: 7216378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of the cat stellate ganglion by angiotensin.
    Aiken JW; Reit E
    J Pharmacol Exp Ther; 1968 Jan; 159(1):107-14. PubMed ID: 4296169
    [No Abstract]   [Full Text] [Related]  

  • 15. Presynaptic inhibition by serotonin of cardiac sympathetic transmission in dogs.
    Kimura T; Satoh S
    Clin Exp Pharmacol Physiol; 1983; 10(5):535-42. PubMed ID: 6315283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a presynaptic inhibitory action of 5-hydroxytryptamine on sympathetic neurotransmission to the myocardium.
    Martinez AA; Lokhandwala MF
    Eur J Pharmacol; 1980 May; 63(4):303-11. PubMed ID: 6248349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bradykinin-induced coronary chemoreflex in the dog.
    Neto FR; Brasil JC; Antonio A
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 283(2):135-42. PubMed ID: 4278014
    [No Abstract]   [Full Text] [Related]  

  • 18. An analysis of the mechanism of 5-hydroxytryptamine-induced vasopressor responses in ganglion-blocked anaesthetized dogs.
    Feniuk W; Hare J; Humphrey PP
    J Pharm Pharmacol; 1981 Mar; 33(3):155-60. PubMed ID: 6116756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the 5-HT-induced cardiogenic hypertensive chemoreflex by the selective 5-HT3 receptor antagonist ICS 205-930.
    Berthold H; Scholtysik G; Engel G
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Mar; 339(3):259-62. PubMed ID: 2725703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impulse transmission via nicotinic and muscarinic pathways in the stellate ganglion of the dog.
    Flacke W; Gillis RA
    J Pharmacol Exp Ther; 1968 Oct; 163(2):266-76. PubMed ID: 4300676
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.